The finding could lead to new treatments for the chronic autoimmune disease, said researchers at Penn State College of Medicine. Systemic lupus erythematosus (SLE) is the most common form of lupus.
In patients with SLE, the immune system forms autoantibodies that attack the body's own cells, causing inflammation and tissue damage.
How these rogue antibodies form is an important area of interest for lupus researchers. When a pathogen like a virus invades the...(continua)